Skip to Main Content

Author Details

Daniel R Gomez
Memorial Sloan Kettering Cancer Center
2005
296
56
PMIDPaper TitleJournal TitlePublished Year
36494075Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers.J Thorac Oncol2023
37795442ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.Front Oncol2023
37540803Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy Efficacy.Cancer Immunol Res2023
37084736Genomic mapping of metastatic organotropism in lung adenocarcinoma.Cancer Cell2023
37097610Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.Clin Cancer Res2023
37294262Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.Pract Radiat Oncol2023
36889516Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.Int J Radiat Oncol Biol Phys2023
36780766Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.Lung Cancer2023
36716413Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall Survival.JCO Precis Oncol2023
36687507Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancer.Phys Imaging Radiat Oncol2023
36640322MDC1 maintains active elongation complexes of RNA polymerase II.Cell Rep2023
36907745Trends in location of death for individuals with metastatic lung cancer in the United States.Am J Surg2023
36603171STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.JCO Precis Oncol2023
36602799Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.JAMA Netw Open2023
34147255The emerging role of local therapy in oligometastatic non-small cell lung cancer.J Thorac Cardiovasc Surg2022
35649502Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective.J Thorac Oncol2022
35544650Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis.JCO Oncol Pract2022
35767426Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer.Clin Cancer Res2022
35644504Radiation Oncology AcaDemic Mentorship Program (ROADMAP) for Junior Faculty: One-Year Results of a Prospective Single Institution Initiative.Int J Radiat Oncol Biol Phys2022
35691448Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTEND.Int J Radiat Oncol Biol Phys2022
36371941Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.Lung Cancer2022
36357680Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.Nat Med2022
36092987Prospective Clinical Evaluation of Integrating a Radiation Anatomist for Contouring in Routine Radiation Treatment Planning.Adv Radiat Oncol2022
36090640Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer.Transl Lung Cancer Res2022
36388248External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors.Clin Transl Radiat Oncol2022
36010969Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer.Cancers (Basel)2022
36085345CtIP-dependent nascent RNA expression flanking DNA breaks guides the choice of DNA repair pathway.Nat Commun2022
35157996Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys2022
35287317Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy ÿ 5 Fractions) for Spine Metastasis.Adv Radiat Oncol2022
35252897Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC.JTO Clin Res Rep2022
35219881How 3 Academic Centers Prescribe Stereotactic Body Radiation Therapy for Primary Lung Cancer.Pract Radiat Oncol2022
34942280Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab.Radiother Oncol2022
35307115The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease.Semin Radiat Oncol2022
35203541Therapeutic Opportunities of Disrupting Genome Integrity in Adult Diffuse Glioma.Biomedicines2022
35051703Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.Cancer Treat Res Commun2022
32331820Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.J Thorac Cardiovasc Surg2021
33492763Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non-small cell lung cancer radiotherapy.J Appl Clin Med Phys2021
33878727Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care.J Natl Compr Canc Netw2021
33851065An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.Adv Radiat Oncol2021
33516442In Reply to Sert.Int J Radiat Oncol Biol Phys2021
33764377Stereotactic Ablative Body Radiotherapy for Metastases Needs Better Evidence-Reply.JAMA Oncol2021
33788624Novel Inpatient Radiation Oncology Consult Service Model Reduces Hospital Length of Stay.JCO Oncol Pract2021
33707003Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.Clin Lung Cancer2021
33920810Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer.Cancers (Basel)2021
33610268Emerging Paradigm of Consolidative Thoracic Radiotherapy in Oligometastatic NSCLC.Semin Radiat Oncol2021
34590050Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC.JTO Clin Res Rep2021
34590042Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC.JTO Clin Res Rep2021
34419505Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC.Radiother Oncol2021
34625293Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73].Lung Cancer2021
34107295Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancer.Radiother Oncol2021
  • 1 - 50 of 296

Recommended Authors

Stanford University
Career Start Year 2014
Number of shared co-authors 3
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 0
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 3
Stanford University
Career Start Year 2012
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 1
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 0
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 5
Emory University
Career Start Year 2011
Number of shared co-authors 1
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 3
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 3
University of Toronto
Career Start Year 2010
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 14
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 8
University of California los angeles
Career Start Year 2007
Number of shared co-authors 1
Maastricht University Medical Centre
Career Start Year 2005
Number of shared co-authors 3
The Ottawa Hospital Research Institute
Career Start Year 2005
Number of shared co-authors 2
German Cancer Research Center (DKFZ)
Career Start Year 2003
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 4
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 6
The University of Manchester
Career Start Year 2000
Number of shared co-authors 9
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 6
University of California san francisco
Career Start Year 1998
Number of shared co-authors 4
University of British Columbia
Career Start Year 1995
Number of shared co-authors 5
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 5
Maastricht University
Career Start Year 1992
Number of shared co-authors 8
Proton Therapy Center- Northwestern University
Career Start Year 1989
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 4
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 12

Collaborators

University of Texas MD Anderson Cancer Center
Co-authored papers 31
The University of Texas MD Anderson Cancer Center
Co-authored papers 25
The University of Texas MD Anderson Cancer Center
Co-authored papers 17
South China University of Technology
Co-authored papers 15
University of Texas MD Anderson Cancer Center
Co-authored papers 12
University of Texas MD Anderson Cancer Center
Co-authored papers 12
Memorial Sloan Kettering Cancer Center
Co-authored papers 11
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
University of Western Ontario
Co-authored papers 9
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
UT Southwestern Medical Center, Center for Human Nutrition
Co-authored papers 6
Co-authored papers 6
Memorial Sloan-Kettering Cancer Center
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Duke University Medical Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
University Health Network, University of Toronto
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
University of Leicester
Co-authored papers 3
Co-authored papers 3